Effect of alogliptin , a DPP-4 inhibitor, on markers of lipid metabolism in type 2 diabetic patients
Phase 4
- Conditions
- type 2 diabetic patients
- Registration Number
- JPRN-UMIN000011470
- Lead Sponsor
- ara Hospital Kinki University Faculty of Medicine
- Brief Summary
The presentation at the 55th Japan Diabetes Society Annual Scientific Meeting
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
patients receiving insulin therapy; severe liver or renal dysfunction; patients with hypersensitivity to alogliptin; patients that had their hypoglycemic agents changed within three months; pregnant women or breast-feeding mothers; and excessive alcohol drinkers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method